CD274 and neoplasm: Tumor cells that overexpress PD-L1 promote PD-1 binding to PD-L1 molecules on their surface, which hinders T cell immune surveillance, makes it more difficult to identify and eliminate tumor cells, and promotes tumor immune escape [17].